NCT01689350View on ClinicalTrials.gov

A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Systemic Lupus Erythematosus
Interventions
GENETIC

Genotype Detection

To Genotype cases in the experimental group and divide them into three groups, including extensive metaboliser (EM), intermediate metaboliser (IM) and poor metaboliser (PM).

Trial Locations (1)

510006

School of Pharmaceutical Sciences Sun Yat-sen University, Guangzhou

All Listed Sponsors
collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

lead

Sun Yat-sen University

OTHER

NCT01689350 - A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment | Biotech Hunter | Biotech Hunter